Samjin to export clopidogrel bisulfate technology to Indonesia

Samjin Pharmaceutical said Monday it has signed a contract ro supply an Indonesian company with a technology that helps the manufacture of clopidogrel bisulfate, an antiplatelet agent used to inhibit blood clots in coronary artery disease, following China and the Philippines.

Under the contract, Samjin will be able to export clopidogrel bisulfate worth $2 million over the next five years aft...